Matches in Wikidata for { <http://www.wikidata.org/entity/Q81230510> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q81230510 description "artículu científicu espublizáu en mayu de 2008" @default.
- Q81230510 description "im Mai 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81230510 description "scientific article published on 01 May 2008" @default.
- Q81230510 description "wetenschappelijk artikel" @default.
- Q81230510 description "наукова стаття, опублікована в травні 2008" @default.
- Q81230510 name "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 name "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 type Item @default.
- Q81230510 label "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 label "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 prefLabel "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 prefLabel "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 P1433 Q81230510-EE04E04D-F347-4DCB-BD8C-2BE2169F3963 @default.
- Q81230510 P1476 Q81230510-4CF79008-DCE2-46D4-B62F-4DF3584F45BC @default.
- Q81230510 P2093 Q81230510-065BD605-5B91-42AB-8B35-60A39C9DB6BF @default.
- Q81230510 P2093 Q81230510-1E75F059-459C-44B3-B483-B5B128C7C84E @default.
- Q81230510 P2093 Q81230510-243A9843-B9E4-477F-82A5-C4B0CAAA4CB0 @default.
- Q81230510 P2093 Q81230510-883E5DE5-C152-4B39-8A23-BA1B8BA91C94 @default.
- Q81230510 P304 Q81230510-CF5A15F0-EEE4-4522-9FA1-A4FF36CE010C @default.
- Q81230510 P31 Q81230510-6D73EC77-1674-4F7F-88CD-367146CDE997 @default.
- Q81230510 P31 Q81230510-f88ac6c2-bba1-4fbc-b7e3-e0b4fd00cabb @default.
- Q81230510 P356 Q81230510-9F86A364-2CEF-4D81-9A23-188D585CC553 @default.
- Q81230510 P433 Q81230510-3720F98A-CF59-4CB5-94D7-DF5C73C9B770 @default.
- Q81230510 P478 Q81230510-59D60C9D-F83D-45AC-98BF-E357B3260059 @default.
- Q81230510 P577 Q81230510-EED55266-570D-473C-A675-4BEACB6D7587 @default.
- Q81230510 P698 Q81230510-4843D806-7AF4-4537-BFF8-20A1452E1070 @default.
- Q81230510 P356 14740338.7.3.241 @default.
- Q81230510 P698 18462183 @default.
- Q81230510 P1433 Q5421206 @default.
- Q81230510 P1476 "Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health" @default.
- Q81230510 P2093 "Fabrice Journé" @default.
- Q81230510 P2093 "Guy Laurent" @default.
- Q81230510 P2093 "Guy Leclercq" @default.
- Q81230510 P2093 "Jean-Jacques Body" @default.
- Q81230510 P304 "241-258" @default.
- Q81230510 P31 Q13442814 @default.
- Q81230510 P31 Q7318358 @default.
- Q81230510 P356 "10.1517/14740338.7.3.241" @default.
- Q81230510 P433 "3" @default.
- Q81230510 P478 "7" @default.
- Q81230510 P577 "2008-05-01T00:00:00Z" @default.
- Q81230510 P698 "18462183" @default.